Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
Clinical trial NCT00849654 · COMPLETED
Trial details
- NCT number
- NCT00849654
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2012-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.